España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Theratechnologies
THTX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.60
-0.21
-11.85%
At close: -
$1.90
0.30
18.75%
After Hours: 9:04 AM EDT
Why is it moving?
Theratechnologies shares are trading lower. The company reported worse-than-expected Q4 EPS results.
Get Report
Comment
Q4 2024 earnings were released today before the market open
Today's conference call ended over 13 hours ago
Click to view the webcast
Theratechnologies (THTX) Forecast
News
Earnings
Theratechnologies (THTX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Theratechnologies (NASDAQ:THTX) Stock
Theratechnologies Stock (NASDAQ: THTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, February 26, 2025
Theratechnologies shares are trading lower. T...
Benzinga Newsdesk
Theratechnologies Q4 2024 GAAP EPS $(0.16) Ma...
Benzinga Newsdesk
Earnings Scheduled For February 26, 2025
Benzinga Insights
Friday, February 14, 2025
Theratechnologies shares are trading higher a...
Benzinga Newsdesk
Reported Earlier, Theratechnologies Resumes D...
Benzinga Newsdesk
Friday, January 10, 2025
Reported Earlier, Theratechnologies Alerts Pa...
Benzinga Newsdesk
Wednesday, December 18, 2024
Theratechnologies Has Submitted A Prior Appro...
Benzinga Newsdesk
Tuesday, December 10, 2024
Theratechnologies Receives March 2025 PDUFA D...
Benzinga Newsdesk
Monday, December 09, 2024
Theratechnologies Announces Preliminary Toler...
Benzinga Newsdesk
Wednesday, December 04, 2024
Theratechnologies Announced It Has Entered In...
Benzinga Newsdesk
Tuesday, December 03, 2024
Theratechnologies Resumes Production Of EGRIF...
Benzinga Newsdesk
Monday, December 02, 2024
Theratechnologies Closed On $40M Three-year N...
Benzinga Newsdesk
Tuesday, November 26, 2024
Theratechnologies Resubmits Supplemental Biol...
Benzinga Newsdesk
Tuesday, November 05, 2024
Foghorn Therapeutics shares are trading highe...
Benzinga Newsdesk
Thursday, October 17, 2024
Theratechnologies Highlights The Impact Of Ex...
Benzinga Newsdesk
Theratechnologies Announces Study Design Of P...
Benzinga Newsdesk
Friday, October 11, 2024
Jones Trading Downgrades Theratechnologies to...
Benzinga Newsdesk
Thursday, October 10, 2024
Theratechnologies shares are trading higher a...
Benzinga Newsdesk
Theratechnologies Lowers FY2024 Sales Guidanc...
Benzinga Newsdesk
Theratechnologies Q3 2024 GAAP EPS $0.06 Beat...
Benzinga Newsdesk
Theratechnologies Q3 2024 Sales $22.600M Miss...
Benzinga Newsdesk
Wednesday, October 09, 2024
Examining the Future: Theratechnologies's Earnings Outlook
Benzinga Insights
Thursday, September 19, 2024
Theratechnologies Faces Potential Supply Disruption For Its Top Selling Drug, Warns of Revenue Impact Due To Manufacturing Delays
Vandana Singh
Tuesday, September 17, 2024
Theratechnologies Expects EGRIFTA SV Supply D...
Benzinga Newsdesk
Theratechnologies Reveals Risk Of Temporary S...
Benzinga Newsdesk
Wednesday, July 10, 2024
HIV Medicine Maker Theratechnologies 'Wraps Up Strong Second Quarter,' Stock Soars
Vandana Singh
Theratechnologies Reiterates FY24 Revenue Gui...
Benzinga Newsdesk
Theratechnologies Q2 Sales $22.02M Beat $21.7...
Benzinga Newsdesk
Thursday, May 23, 2024
Theratechnologies Says Sudocetaxel Zendusorti...
Benzinga Newsdesk
Thursday, May 02, 2024
Theratechnologies Will Present Long-term Effi...
Benzinga Newsdesk
Wednesday, April 10, 2024
Theratechnologies Q1 EPS $(0.10) Beats $(0.12...
Benzinga Newsdesk
Earnings Scheduled For April 10, 2024
Benzinga Insights
Monday, April 08, 2024
Theratechnologies Presents Preclinical Data T...
Benzinga Newsdesk
Friday, March 22, 2024
Theratechnologies Says Phasing Down Of Resear...
Benzinga Newsdesk
Theratechnologies Announces Update On Its Pre...
Benzinga Newsdesk
Wednesday, February 21, 2024
Theratechnologies Forecasts Fiscal Year 2024 ...
Benzinga Newsdesk
Theratechnologies Q4 EPS $(0.08) May Not Be C...
Benzinga Newsdesk
Earnings Scheduled For February 21, 2024
Benzinga Insights
Tuesday, February 20, 2024
Theratechnologies Earnings Preview
Benzinga Insights
Wednesday, January 24, 2024
Trading Halt: Halt status updated at 7:25:00 ...
Benzinga Newsdesk
Theratechnologies Receives Complete Response ...
Benzinga Newsdesk
Trading Halt: Halted at 6:55:00 a.m. ET - Tra...
Benzinga Newsdesk
Tuesday, January 23, 2024
Theratechnologies Has Received FDA Correspond...
Benzinga Newsdesk
Tuesday, January 02, 2024
Theratechnologies Submits sBLA for Trogarzo I...
Benzinga Newsdesk
Thursday, December 21, 2023
Theratechnologies Inc Files For Mixed Shelf F...
Benzinga Newsdesk
Wednesday, December 13, 2023
Theratechnologies Says FDA Approved Labelling...
Benzinga Newsdesk
Thursday, November 02, 2023
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Thursday, October 26, 2023
Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Theratechnologies shares are trading lower af...
Benzinga Newsdesk
Why Endeavor Group Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Show More
